Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AKTS compared with EIKN: revenue, margins and what each company keeps, and the suppliers and customers both name
AKTS
Aktis Oncology, Inc.
Change
Mkt cap
Revenue
Revenue
EIKN
Eikon Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AKTS
Aktis Oncology, Inc.
vs
EIKN
Eikon Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AKTS, solid
EIKN, dashed
AKTS
Aktis Oncology, Inc.
Change
15.87
▲
+6.88%
· post 15.87
Mkt cap
$874.8M
Revenue
$3M
Q2 FY26
EIKN
Eikon Therapeutics, Inc.
Change
5.96
▲
+2.01%
· post 5.96
Closed
Nov 6 '26
Mkt cap
$319.4M
Revenue
—
vs
Compare
Closed
Nov 6 '26
AKTS
Aktis Oncology, Inc.
vs
EIKN
Eikon Therapeutics, Inc.
15.87
▲
+6.88%
post 15.87
Price
5.96
▲
+2.01%
post 5.96
$874.8M
Mkt cap
$319.4M
Q2 FY26
$3M
Revenue
—
Change
Change
AKTS
15.87
▲
+6.88%
vs
EIKN
5.96
▲
+2.01%
Closed
Nov 6 '26